Advertisement

etomidate Injection

[14 July 2015]

Products Affected - Description

Etomidate injection, American Regent
2 mg/mL, 10 mL vial, 10 count (NDC 00517-0780-10)
2 mg/mL, 20 mL vial, 10 count (NDC 00517-0781-10)
 
Amidate injection, Hospira
2 mg/mL, 20 mL LifeShield syringes, 10 count (NDC 00409-8060-29)
 
Etomidate injection, Par Sterile Products
2 mg/mL, 10 mL vial (NDC 42023-0169-10) - discontinued
2 mg/mL, 20 mL vial (NDC 42023-0170-10) - discontinued

Etomidate injection, Sagent
2 mg/mL, 10 mL vial, 10 count (NDC 25021-0674-10)
2 mg/mL, 20 mL vial, 10 count (NDC 25021-0674-20)

Reason for the Shortage

  • American Regent has etomidate injection on shortage due to manufacturing delays.
  • Ben Venue stopped production in its plant in Bedford, Ohio and closed in July 2014.
  • Hospira has Amidate injection on shortage due to increased demand.
  • Par Sterile Products discontinued etomidate in early 2015.

Available Products

Etomidate injection, Mylan Institutional
2 mg/mL, 10 mL vial, 10 count (NDC 00069-0006-01)
2 mg/mL, 20 mL vial, 10 count (NDC 00069-0006-03)
 
Amidate intravenous injection, Hospira
2 mg/mL, 10 mL ampule, 5 count (NDC 00409-8062-01)
2 mg/mL, 10 mL vial, 10 count (NDC 00409-6695-01)
2 mg/mL, 20 mL ampule, 5 count (NDC 00409-8061-01)
2 mg/mL, 20 mL vial, 10 count (NDC 00409-6695-02)

Estimated Resupply Dates

  • American Regent has etomidate 10 mL and 20 mL vials on back order and the company cannot estimate a release date.
  • Hospira has Amidate 2 mg/mL 20 mL LifeShield syringes on back order and the company estimates a release date of early-August 2015.
  • Sagent has etomidate 10 mL and 20 mL vials on back order and the company cannot estimate a return date as production has been suspended.

Safety

Clinicians must take extra care to ensure safe use of etomidate when using different presentations than those normally stocked.

Related Shortages

Updated

July 14, June 15, May 15, April 16, 17 and 28, March 2 and 23, February 12, 2015; December 18 and 22, October 3, September 5, August 1 and 7, July 8 and 15, May 16, April 16, March 20 and 31, February 21 and 27, January 24, 2014; December 6 and 12, October 9 and 24, July 25, June 11 and 27, May 7 and 28, April 3, 9, and 23, March 8, February 13 and 25, January 11, 22, 29, and 31, 2013; December 7 and14, November 5 and19, October 4, September 14, August 7, July 19 and 25, June 18, May 2 and 29, April 3, March 2, 14, February 7, 14, and 27, January 3, 27, and 31, 2012; December 6 and19, October 26, August 3 and 31, July 6, 2011, University of Utah, Drug Information Service. Copyright 2015, University of Utah, Drug Information Service.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement